Latest US Food and Drug Administration Stories
Drug maker GlaxoSmithKline released a new report detailing that its antidepressant Paxil could potentially make people with major depression more likely to become suicidal.
A new drug shown to help prolong the lives of people suffering from advanced skin cancer has been approved by the FDA.
WAYNE, N.J., March 25, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
Following the recent FDA approval of the expanded LAP-BAND® System indication for patients with lower weight requirements, DayOne Health, a leading Chicago outpatient weight loss program, is now offering an affordable self-pay option for the newly qualified low BMI LAP-BAND® patients.
A drug for high-risk pregnant women that once cost between $10 to $20 per injection will next week cost $1,500 a dose, meaning the total cost during a pregnancy could be as much as $30,000.
MONMOUTH JUNCTION, N.J., March 9, 2011 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced today that the US Food and Drug Administration (FDA) has accepted its Extended Release Carbinoxamine Oral Suspension NDA for the treatment of allergies in kids two years and older.
Reynolds and Lorillard, the second- and third-biggest US cigarette makers, filed suit to block the FDA from receiving recommendations from an advisory committee that the cigarette makers claim have conflicts of interest.
EAST HANOVER, N.J., Feb.
Contrave Disallowed Pending Further Large-Scale Testing SILVER SPRING, Md., Feb.
SAN DIEGO, Jan. 27, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today a reduction of its US workforce of approximately 25%, or 66 employees.
- Having no light.